Sangamo Therapeutics Statistics
Total Valuation
SGMO has a market cap or net worth of $111.85 million. The enterprise value is $117.70 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMO has 414.27 million shares outstanding. The number of shares has increased by 38.92% in one year.
| Current Share Class | 414.27M |
| Shares Outstanding | 414.27M |
| Shares Change (YoY) | +38.92% |
| Shares Change (QoQ) | +11.00% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 15.29% |
| Float | 406.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.83 |
| Forward PS | 1.54 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2,891.84% and return on invested capital (ROIC) is -204.98%.
| Return on Equity (ROE) | -2,891.84% |
| Return on Assets (ROA) | -83.66% |
| Return on Invested Capital (ROIC) | -204.98% |
| Return on Capital Employed (ROCE) | -625.06% |
| Weighted Average Cost of Capital (WACC) | 10.10% |
| Revenue Per Employee | $278,535 |
| Profits Per Employee | -$865,718 |
| Employee Count | 142 |
| Asset Turnover | 0.49 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -568,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.42% in the last 52 weeks. The beta is 1.50, so SGMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -63.42% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 40.39 |
| Average Volume (20 Days) | 7,226,221 |
Short Selling Information
The latest short interest is 37.61 million, so 9.08% of the outstanding shares have been sold short.
| Short Interest | 37.61M |
| Short Previous Month | 33.48M |
| Short % of Shares Out | 9.08% |
| Short % of Float | 9.24% |
| Short Ratio (days to cover) | 8.03 |
Income Statement
In the last 12 months, SGMO had revenue of $39.55 million and -$122.93 million in losses. Loss per share was -$0.44.
| Revenue | 39.55M |
| Gross Profit | -73.12M |
| Operating Income | -108.00M |
| Pretax Income | -123.50M |
| Net Income | -122.93M |
| EBITDA | -104.04M |
| EBIT | -108.00M |
| Loss Per Share | -$0.44 |
Full Income StatementBalance Sheet
The company has $20.95 million in cash and $26.80 million in debt, with a net cash position of -$5.85 million or -$0.01 per share.
| Cash & Cash Equivalents | 20.95M |
| Total Debt | 26.80M |
| Net Cash | -5.85M |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -14.27M |
| Book Value Per Share | -0.04 |
| Working Capital | -6.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$97.21 million and capital expenditures -$102,000, giving a free cash flow of -$97.31 million.
| Operating Cash Flow | -97.21M |
| Capital Expenditures | -102,000 |
| Depreciation & Amortization | 3.96M |
| Net Borrowing | n/a |
| Free Cash Flow | -97.31M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
| Gross Margin | -184.87% |
| Operating Margin | -273.07% |
| Pretax Margin | -312.25% |
| Profit Margin | n/a |
| EBITDA Margin | -263.05% |
| EBIT Margin | -273.07% |
| FCF Margin | n/a |
Dividends & Yields
SGMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.92% |
| Shareholder Yield | -38.92% |
| Earnings Yield | -109.90% |
| FCF Yield | -87.00% |
Analyst Forecast
The average price target for SGMO is $7.00, which is 2,492.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 2,492.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 69.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGMO has an Altman Z-Score of -42.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -42.19 |
| Piotroski F-Score | 2 |
